Clinical trial
INSULIN THERAPY DE-INTENSIFICATION WITH iGlarLixi
NCT04945070 is registered in ClinicalTrials.gov with Institute for Clinical and Experimental Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- INSULIN THERAPY DE-INTENSIFICATION WITH iGlarLixi
- Lead sponsor
- Institute for Clinical and Experimental Medicine
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- July 31, 2021
- Completion date
- June 30, 2023
- Enrollment
- 96 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes treated with insulin